Skip to main content

Advertisement

Log in

Surveillance of HIV and Viral Hepatitis by Analysis of Samples from Drug Related Deaths

  • Infectious Diseases
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Objectives:

To determine the prevalence of antibodies against HIV, hepatitis B (HBV) and hepatitis C (HCV) in postmortem samples from drug related deaths (DRDs) in Denmark.

Design:

Prospective cohort study. Postmortem samples tested for anti-HIV, anti-HCV anti-HBc and anti-HBs. Comparison to pre-mortem testing when possible. DRDs were searched for in the national register of drug treatment, national prison registers, and the national infectious disease register.

Setting:

National level.

Participants:

Drug related deaths admitted to Danish Institutes of Forensic Medicine during 2004.

Main outcome measures:

Prevalence of antibodies, injection drug use, drug treatment experience and prevalence of cirrhosis.

Results:

Samples for analysis were obtained from 78% (233/299) of DRDs. The prevalences of anti-HIV, anti-HCV and anti-HBc were 4% (9/214), 51% (110/215), and 35% (74/209), indicating a persisting low prevalence of HIV and a declining prevalence of HCV and HBV. Injecting ever was detected among 45% of DRDs and this was associated with a significantly higher prevalence of hepatitis B and C. Among the DRDs 56% received drug treatment and 12% had cirrhosis at autopsy. Evidence of vaccination against HBV was found among 16% (21/128).

Conclusions:

Monitoring of viral hepatitis and HIV among DRDs is feasible, and our survey indicates a falling prevalence among Danish drug users. Surveillance based on drug users in treatment may overestimate the true prevalence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. EMCDDA. Annual report 2005: The state of the drug problems in Europe 2005

  2. Cattaneo C, Nuttall PA, Molendini LO, Pellegrinelli M, Grandi M, Sokol RJ. Prevalence of HIV and hepatitis C markers among a cadaver population in Milan J Clin Pathol 1999; 52: 267–270

    Article  PubMed  CAS  Google Scholar 

  3. Coe JI. Postmortem chemistry update. Emphasis on forensic application Am J Forensic Med Pathol 1993; 14:91–117

    Article  PubMed  CAS  Google Scholar 

  4. Li L, Zhang X, Constantine NT, Smialek JE. Seroprevalence of parenterally transmitted viruses (HIV-1, HBV, HCV, and HTLV-I/II) in forensic autopsy cases J Forensic Sci 1993; 38:1075–1083

    PubMed  CAS  Google Scholar 

  5. du-Plessis R, Webber L, Saayman G. Bloodborne viruses in forensic medical practice in South Africa Am J Forensic Med Pathol 1999; 20:364–368

    Article  PubMed  CAS  Google Scholar 

  6. Brazinsky JH, Kellenberger RE. Comparison of immunoglobulin analyses of antemortem and postmortem sera Am J Clin Pathol 1970; 54:622–624

    PubMed  CAS  Google Scholar 

  7. Klatt EC, Shibata D, Strigle SM. Postmortem enzyme immunoassay for human immunodeficiency virus Arch Pathol Lab Med 1989; 113:485–487

    PubMed  CAS  Google Scholar 

  8. Pepose JS, Pardo F, Kessler JA, Kline R, Donegan E, Quinn TC. Screening cornea donors for antibodies against human immunodeficiency virus. Efficacy of ELISA testing of cadaveric sera and aqueous humor Ophthalmology 1987; 94:95–100

    PubMed  CAS  Google Scholar 

  9. Stofmisbrugere i Danmark 2001 [Drug users in Denmark 2001] Nye Tal Fra Sundhedsstyrelsen 2003; 7:16, 1–9

    Google Scholar 

  10. Heim A, Wagner D, Rothamel T, Hartmann U, Flik J, Verhagen W. Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation J Med Virol 1999; 58:291–295

    Article  PubMed  CAS  Google Scholar 

  11. Lockemann U., Puschel K. HIV-1 prevalence among drug deaths – a multicenter study Forensic Sci Int 1993; 62:89–93

    Article  PubMed  CAS  Google Scholar 

  12. Karhunen PJ, Brummer-Korvenkontio H, Laaksonen H, Kantanen ML, Arstila P, Leinikki P. Surveillance of human immunodeficiency virus (HIV) antibodies in medicolegal autopsies in Finland–monitoring early changes in HIV-seropositivity among risk groups and average population J Forensic Sci 1992; 37:1261–1268

    PubMed  CAS  Google Scholar 

  13. Kringsholm B, Theilade P. Prevalence of HIV-1 antibodies in drug addicts autopsied at the University Institute of Forensic Pathology in Copenhagen 1988–1991 Forensic Sci Int 1992; 55:83–92

    Article  PubMed  CAS  Google Scholar 

  14. Christensen PB, Krarup HB, Niesters HG, Norder H, Georgsen J. Prevalence and incidence of bloodborne viral infections among Danish prisoners Eur J Epidemiol 2000; 16:1043–1049

    Article  PubMed  CAS  Google Scholar 

  15. Fuglsang T, Fouchard JR, Ege PP. Udbredelsen af hiv og hepatitis B og C blandt københavnske stofmisbrugere. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen] Ugeskr Laeger 2000; 162:3860–3864

    PubMed  CAS  Google Scholar 

  16. Kringsholm B, Franzmann M. (2005) Liver Pathology in Fatal Drug Addiction. Abstract presented at the 17 Meeting of the International Association of Forensic Sciences. 408

  17. Stofmisbrugere i behandling 2004 [Drug users in treatment 2004]. Nye Tal Fra Sundhedsstyrelsen 2005; 12:1–24

    Google Scholar 

  18. Dødelighed og dødsårsager blandt stofmisbrugere indskrevet i behandling i 1996 [Mortality and causes of death among drug users in treatment 1966] Nye Tal Fra Sundhedsstyrelsen 1999; 3:3, 1–18

  19. Trubner K, Polywka S, Puschel K, Laufs R. Hepatitis C in deceased drug addicts Int J Legal Med 1991; 104:251–254

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Eva Hammerby, Sigrid Poulsen, Peter Ege and Else Smith for ideas and comments, Lone Tønning Sørensen and Sussi Mortensen for technical support with postmortem analysis. Financial support was obtained from the Danish National Board of Health and the European Network on Drugs and Infections Prevention in Prison (ENDIPP).

The views expressed in this paper are the responsibility of the authors and not necessarily those of the National Board of Health or ENDIPP.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peer Brehm Christensen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Christensen, P.B., Kringsholm, B., Banner, J. et al. Surveillance of HIV and Viral Hepatitis by Analysis of Samples from Drug Related Deaths. Eur J Epidemiol 21, 383–387 (2006). https://doi.org/10.1007/s10654-006-9009-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-006-9009-x

Keywords

Navigation